# Observational Study in Patients With Schizophrenia Treated With Long-Acting Risperidone Injection (RISPERDAL CONSTA)

> **NCT00246194** · — · COMPLETED · sponsor: **Janssen, LP** · enrollment: 532 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** risperidone (RISPERDAL CONSTA)

## Key facts

- **NCT ID:** NCT00246194
- **Lead sponsor:** Janssen, LP
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2007-11
- **Final completion:** 2007-11
- **Target enrollment:** 532 (ACTUAL)
- **Last updated:** 2014-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00246194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00246194, "Observational Study in Patients With Schizophrenia Treated With Long-Acting Risperidone Injection (RISPERDAL CONSTA)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00246194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*